Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Mr. Eduardo Guarita Bezerra

Executive Vice President & Chief Financial Officer

Mr. Ronald C. Janish

Chief Transformation Officer and Executive Vice President of Global Operations & Supply Chain

Ms. Kyle L. Hanson

Executive Vice President, General Counsel & Corporate Secretary

Mr. Shannon  Hukill

Senior Director of Technical Operations

Mr. Patrick  Lockwood-Taylor

President, Chief Executive Officer & Director

Mr. Svend  Andersen

Executive Vice President & President of Consumer Self-Care International

Mr. Thomas M. Farrington

Chief Information Officer & Executive Vice President

Ms. Mary  Reilly-Brest

Director of Global Organizational and Human Resource Development

Mr. Bradley  Joseph

Vice President of Global Investor Relations & Corporate Communications

Ms. Alison  Ives

Executive Vice President & Chief Scientific Officer

Pavadinimas	Rinkos kapitalizacija
China Medical System Holdings Limited	0M
TILT Holdings Inc.	0M
ZhuZhou QianJin Pharmaceutical Co.,Ltd	0M
Wockhardt Limited	0M
Chong Kun Dang Pharmaceutical Corp.	0.1M
Jiang Zhong Pharmaceutical Co.,Ltd	0M
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	0M
Hainan Shuangcheng Pharmaceuticals Co., Ltd.	0M
Eris Lifesciences Limited	0M
Shenzhen Kangtai Biological Products Co., Ltd.	0M
Medical Developments International Limited	0M

Perrigo Company plc

Perrigo Company plc Konkurentų sąrašas

Pagrindiniai konkurentai